ASX:NVO Novo Resources (NVO) Stock Price, News & Analysis → Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad) Free NVO Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Novo Resources alerts: Email Address Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. About Novo Resources Stock (ASX:NVO)Novo Resources Corp., together with its subsidiaries, engages in evaluating, acquiring, exploring, and developing natural resource properties in Canada, Australia, and the United States. The company primarily explores for gold deposits. It holds approximately 7,500 sq km of land in the Pilbara region of Western Australia, as well as interests in various projects located in Victoria, Australia. The company was formerly known as Galliard Resources Corp. and changed its name to Novo Resources Corp. in June 2011. Novo Resources Corp. was incorporated in 2009 and is headquartered in Vancouver, Canada.Read More Ad Crypto 101 MediaTop Project Outperforms BTC in 2023…According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.Just click here for instant access to the #1 Coin for 2024. NVO Stock News HeadlinesMarch 28, 2024 | theguardian.comStudy: ‘gamechanger’ diabetes drugs cost up to 400 times more than neededMarch 28, 2024 | msn.comThe Surprising Way You Can Lower Employee StressMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 28, 2024 | stockhouse.comAppointment of Ms Karen O'Neill as DirectorMarch 28, 2024 | finance.yahoo.comNovo Resources sees substantial upside potential at NunyerryMarch 27, 2024 | juniorminingnetwork.comNovo Resources: Upgraded Nunyerry North Drill Results Deliver High-Grade Intercepts Up to 6.12 g/t AuMarch 27, 2024 | msn.comWeight loss drugs firm expands into heart disease treatmentMarch 27, 2024 | juniorminingnetwork.comNovo Resources: Appointment of Ms Karen O’Neill as DirectorMarch 29, 2024 | Gold Safe Exchange (Ad)Trump’s “Tax Free” Retirement Strategy Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.March 21, 2024 | msn.comNovo Nordisk goes ex dividend tomorrowMarch 20, 2024 | ca.investing.comEli Lilly , Novo Nordisk shares slide after CBO comments on obesity drugsMarch 19, 2024 | bloomberg.comNovo Foundation, Nvidia Team Up to Build Danish AI SupercomputerMarch 18, 2024 | finanznachrichten.deNovo Nordisk Foundation: Denmark to build one of the world's most powerful AI supercomputers, accelerating solutions to societal challengesMarch 13, 2024 | reuters.comKimmeridge makes new $2.1 bln offer for SilverBow, sources sayMarch 11, 2024 | finanznachrichten.deNovo Nordisk: Wegovy receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesityMarch 9, 2024 | theglobeandmail.comClosing Bell: Novo Resources Corp up on Friday (NVO)March 8, 2024 | msn.comNovo Nordisk sees launching new obesity drugs before Wegovy patent expiresMarch 7, 2024 | msn.comNovo Nordisk expects Wegovy approval in China this year: reportMarch 7, 2024 | finance.yahoo.comNovo Resources Corp. (1NO.F)March 7, 2024 | bloomberg.comNovo Nordisk Surges to Record on Experimental Obesity Pill DataMarch 7, 2024 | msn.comNovo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialMarch 5, 2024 | msn.comNovo Nordisk Says Famed Diabetes Medicine Ozempic Reduces Risk Of Kidney Disease Progression, Data ShowsMarch 4, 2024 | benzinga.comWhat the Options Market Tells Us About Novo NordiskFebruary 29, 2024 | au.finance.yahoo.comNovo Resources Corp. (NVO.AX)February 28, 2024 | finance.yahoo.comProposed Board and Leadership RenewalFebruary 27, 2024 | msn.comDenmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economyFebruary 20, 2024 | markets.businessinsider.com7 Analysts Assess Novo Nordisk: What You Need To KnowSee More Headlines Receive NVO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Novo Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorBasic Materials Industry Gold Sub-IndustryN/A Current SymbolASX:NVO CUSIPN/A CIKN/A Webwww.nvoi.com.au Phone1300 687 179FaxN/AEmployees75Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.18) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-48,890,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-35.83% Return on Assets-13.65% Debt Debt-to-Equity Ratio1.90 Current Ratio2.66 Quick Ratio4.30 Sales & Book Value Annual Sales$2.50 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow2.25 Book ValueA$0.24 per share Price / BookN/AMiscellaneous Outstanding Shares353,060,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta1.55 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Michael John Spreadborough MBAExecutive Co-Chairman & Acting CEOMs. Karen De LucaGeneral Manager of ExplorationMs. Elza van der WaltCFO & Joint Corporate SecretaryMs. Lisa SmithGeneral Counsel & Joint Corporate SecretaryMr. Alwin van RoijSenior Exploration GeologistKey CompetitorsAben MineralsOTCMKTS:ABNAFAdelong GoldASX:ADGAlacer GoldOTCMKTS:ALIAFALACERGOLD/IDR UNRESTRASX:AQGAlchemy ResourcesASX:ALYView All Competitors This page (ASX:NVO) was last updated on 3/29/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Resources Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.